(Q33929187)

English

Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials. Blood Pressure Lowering Treatment Trialists' Collaboration

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

30 July 2017

0 references

Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials. Blood Pressure Lowering Treatment Trialists' Collaboration (English)

1 reference

Europe PubMed Central

30 July 2017

1 reference

based on heuristic

inferred from title

Charles S. Algert

1 reference

ORCID Public Data File 2021

author name string

B Neal

1

1 reference

Europe PubMed Central

30 July 2017

S MacMahon

2

1 reference

Europe PubMed Central

30 July 2017

N Chapman

3

1 reference

Europe PubMed Central

30 July 2017

Blood Pressure Lowering Treatment Trialists' Collaboration

4

1 reference

Europe PubMed Central

30 July 2017

language of work or name

0 references

publication date

1 December 2000

1 reference

Europe PubMed Central

30 July 2017

1 reference

Europe PubMed Central

30 July 2017

356

1 reference

Europe PubMed Central

30 July 2017

9246

1 reference

Europe PubMed Central

30 July 2017

1955-1964

1 reference

Europe PubMed Central

30 July 2017

Blood pressure, stroke, and coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903307-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Blood pressure, antihypertensive drug treatment and the risks of stroke and of coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903307-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of antihypertensive drug treatment on cardiovascular outcomes in women and men. A meta-analysis of individual patient data from randomized, controlled trials. The INDANA Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903307-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Health outcomes associated with antihypertensive therapies used as first-line agents. A systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903307-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Blood pressure, stroke, and coronary heart disease. Part 1, Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903307-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Cholesterol, diastolic blood pressure, and stroke: 13 000 strokes in 450 000 people in 45 prospective cohorts

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903307-9

7 January 2021

based on heuristic

inferred from DOI database lookup

MRC trial of treatment of mild hypertension: principal results. Medical Research Council Working Party

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903307-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Medical Research Council trial of treatment of hypertension in older adults: principal results. MRC Working Party

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903307-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Beta-blockers versus diuretics in hypertensive men: main results from the HAPPHY trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903307-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Cardiovascular risk and risk factors in a randomized trial of treatment based on the beta-blocker oxprenolol: the International Prospective Primary Prevention Study in Hypertension (IPPPSH). The IPPPSH Collaborative Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903307-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Department of veterans Affairs single-drug therapy of hypertension study. Revised figures and new data. Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903307-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Final outcome results of the Multicenter Isradipine Diuretic Atherosclerosis Study (MIDAS). A randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903307-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Beta blockade during and after myocardial infarction: an overview of the randomized trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903307-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. Collaborative Group on ACE Inhibitor Trials.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903307-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Emerging role of angiotensin-converting enzyme inhibitors in cardiac and vascular protection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903307-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Calcium channel blockers in acute myocardial infarction and unstable angina: an overview

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903307-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Update of effects of calcium antagonists in myocardial infarction or angina in light of the second Danish Verapamil Infarction Trial (DAVIT-II) and other recent studies.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903307-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients. ACE-Inhibitor Myocardial Infarction Collaborative Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903307-9

7 January 2021

based on heuristic

inferred from DOI database lookup

The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non-insulin-dependent diabetes and hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903307-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903307-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903307-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomised trial of effects of calcium antagonists compared with diuretics and beta-blockers on cardiovascular morbidity and mortality in hypertension: the Nordic Diltiazem (NORDIL) study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903307-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903307-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903307-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903307-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized, placebo-controlled trial of the angiotensin-converting enzyme inhibitor, ramipril, in patients with coronary or other occlusive arterial disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903307-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of amlodipine on the progression of atherosclerosis and the occurrence of clinical events. PREVENT Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903307-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Angiotensin-converting enzyme inhibition as antiatherosclerotic therapy: no answer yet. QUIET Investigators. QUinapril Ischemic Event Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903307-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term effects of cholesterol lowering and angiotensin-converting enzyme inhibition on coronary atherosclerosis: The Simvastatin/Enalapril Coronary Atherosclerosis Trial (SCAT).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903307-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903307-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903307-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical results of the Verapamil in Hypertension and Atherosclerosis Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903307-9

7 January 2021

based on heuristic

inferred from DOI database lookup

The Verapamil in Hypertension and Atherosclerosis Study (VHAS): results of long-term randomized treatment with either verapamil or chlorthalidone on carotid intima-media thickness

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903307-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Trials stopped early: too good to be true?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903307-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0140-6736(00)03307-9

1 reference

Europe PubMed Central

30 July 2017

1 reference

Europe PubMed Central

30 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33929187&oldid=1909353282"